Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports the design of compounds targeting tyrosine kinase receptors, which play a role in tumor growth and progression. The compound's fluorinated indolinone core enhances binding selectivity and metabolic stability in drug candidates. It is also explored in the preparation of bioactive molecules for neurological and inflammatory disorders due to its favorable pharmacokinetic properties.